CARRY WEALTH (00643) received the original injunction order issued by the High Court of Hong Kong.
Heng Fu Holdings (00643) announced that on June 30, 2026, the company received an original stop notice issued by the Hong Kong High Court pursuant to Order 11 of Rule 50 of the Hong Kong High Court Rules. The notice was filed by Giant International Development Limited (the applicant) aiming to restrict the transfer of 411 million shares of the company (subject shares) currently registered under MARS Worldwide Holdings Limited (MARS Worldwide), as well as the payment of any dividends or interests on those shares, until a 14-day notice is issued to the applicant's legal representative.
CARRY WEALTH (00643) announces that on June 30, 2026, the company received an original stop notice issued by the High Court of Hong Kong under Order 11 of Rule 50 of the High Court of Hong Kong Rules (the Stop Notice). The notice was filed by Giant Run International Development Limited (the Applicant) and aims to restrict the transfer of 4.11 billion shares of the company currently registered under MARS Worldwide Holdings Limited (MARS Worldwide), as well as the payment of any dividends or interest on those shares, until a 14-day notice is given to the legal representative of the Applicant. The reason for issuing the Stop Notice is based on an alleged default event in the loan agreement signed on April 14, 2026 (involving, among others, the Applicant as the lender and Zephyrus Capital Limited as the borrower), and the security account mortgage terms signed between MARS Worldwide as the chargor and the Applicant as the chargee on April 14, 2026, as the beneficial owner of those targeted shares (the Allegation).
The Board of Directors has made inquiries to Mr. Sun Bangui (Mr. Sun) regarding the Allegation and Mr. Sun has informed them that he does not agree with the Allegation, and if the Applicant and Zephyrus cannot reach a settlement, he may take legal action against the Applicant. Mr. Sun also intends to apply to the High Court to revoke the Stop Notice as soon as practicable.
As of the date of this announcement, the relevant shares are held by MARS Worldwide, which is fully owned by Zephyrus Capital Limited, and Zephyrus Capital Limited is beneficially owned 97% by Mr. Sun and 3% by Ms. Zhu Ruipeng.
Based on current assessment, and as of the date of this announcement, the company believes that the Stop Notice will not have an immediate direct impact on the company's business operations and financial condition. The company may seek legal advice before taking any further action to protect its interests.
The company will continue to closely monitor the latest developments of the Stop Notice and will issue further announcements in accordance with the Listing Rules to update on relevant progress when appropriate.
At the company's request, trading of the shares on the Exchange was suspended on the morning of July 2, 2026, pending the publication of this announcement. The company has applied to the Exchange to resume trading of the shares on the Exchange from the afternoon of July 2, 2026.
Related Articles

HK Stock Market Move | IMAGI INT'L (00585) rose 24% today. Since the beginning of April, the stock price has risen more than 7.6 times. The long-term investment value of the company is being revalued by the market at an accelerating pace.

Relying on the efficient platform technology, IMMUNEONCO-B (01541) is promoting the upgrade of the IMM2510 formulation, improving the convenience and compliance of cancer patient treatment.

PASHUN INT'L (00574) will be suspended in the afternoon of July 2nd awaiting the publication of insider information.
HK Stock Market Move | IMAGI INT'L (00585) rose 24% today. Since the beginning of April, the stock price has risen more than 7.6 times. The long-term investment value of the company is being revalued by the market at an accelerating pace.

Relying on the efficient platform technology, IMMUNEONCO-B (01541) is promoting the upgrade of the IMM2510 formulation, improving the convenience and compliance of cancer patient treatment.

PASHUN INT'L (00574) will be suspended in the afternoon of July 2nd awaiting the publication of insider information.

RECOMMEND





